Alliancebernstein L.P. Heron Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$278 Billion
Q2 2024

A detailed history of Alliancebernstein L.P. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 198,550 shares of HRTX stock, worth $379,230. This represents 0.0% of its overall portfolio holdings.

Number of Shares

198,550

Previous 165,030 20.31%

Holding current value

$379,230

Previous $457,000 51.86%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.32 - $3.86 $77,766 - $129,387	33,520 Added 20.31%	198,550 $694,000
Q1 2024 May 14, 2024	SELL	$1.71 - $3.06 $48,888 - $87,485	-28,590 Reduced 14.77%	165,030 $457,000
Q2 2023 Aug 15, 2023	BUY	$1.11 - $2.88 $18,559 - $48,153	16,720 Added 9.45%	193,620 $224,000
Q4 2022 Feb 14, 2023	BUY	$2.25 - $4.67 $36,225 - $75,187	16,100 Added 10.01%	176,900 $442,000
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $502,549 - $1.37 Million	-218,500 Reduced 57.61%	160,800 $449,000
Q1 2022 May 13, 2022	BUY	$4.63 - $9.94 $1.16 Million - $2.49 Million	250,300 Added 194.03%	379,300 $2.17 Million
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $117,735 - $177,660	-14,100 Reduced 9.85%	129,000 $1.18 Million
Q2 2021 Jul 30, 2021	SELL	$13.27 - $18.48 $766,369 - $1.07 Million	-57,752 Reduced 28.75%	143,100 $2.22 Million
Q3 2020 Nov 12, 2020	SELL	$13.67 - $17.77 $967,535 - $1.26 Million	-70,778 Reduced 26.06%	200,852 $2.98 Million
Q2 2020 Aug 13, 2020	BUY	$10.89 - $21.47 $119,790 - $236,170	11,000 Added 4.22%	271,630 $4 Million
Q1 2020 May 14, 2020	BUY	$10.23 - $24.56 $1.38 Million - $3.32 Million	135,030 Added 107.51%	260,630 $3.06 Million
Q4 2019 Feb 18, 2020	BUY	$17.42 - $26.61 $54,002 - $82,491	3,100 Added 2.53%	125,600 $2.95 Million
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $629,677 - $975,200	-37,193 Reduced 23.29%	122,500 $2.28 Million
Q1 2019 May 14, 2019	BUY	$23.15 - $28.34 $1.31 Million - $1.6 Million	56,493 Added 54.74%	159,693 $3.9 Million
Q2 2018 Aug 13, 2018	BUY	$26.4 - $42.0 $1.24 Million - $1.97 Million	46,900 Added 83.3%	103,200 $4.01 Million
Q1 2018 May 14, 2018	SELL	$18.43 - $28.8 $1.01 Million - $1.57 Million	-54,600 Reduced 49.23%	56,300 $1.55 Million
Q4 2017 Feb 13, 2018	BUY	$14.8 - $18.85 $667,480 - $850,135	45,100 Added 68.54%	110,900 $2.01 Million
Q3 2017 Nov 13, 2017	BUY	$14.65 - $16.85 $963,970 - $1.11 Million	65,800	65,800 $1.06 Million

Others Institutions Holding HRTX

# of Institutions

193

Shares Held

129M

Call Options Held

94.7K

Put Options Held

148K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $227M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Heron Therapeutics, Inc. Transaction History